AGENSYS
Agensys a biotechnology company, engages in the research and development of therapeutic human monoclonal antibodies and antibody drug conjugates for the treatment of cancer. It offers products to treat various tumors, as well as prostate, pancreatic, and bladder cancers. The company, formerly known as UroGenesys, was founded in 1997 and is based in Santa Monica, California. As of December 18, 2007, Agensys, Inc. operates as a subsidiary of Astellas Pharma US, Inc.
AGENSYS
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Founded:
1997-01-01
Address:
Santa Monica, California, United States
Country:
United States
Website Url:
http://www.agensys.com
Total Employee:
251+
Status:
Active
Contact:
310-820-8029
Total Funding:
106.4 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Current Employees Featured
Founder
Investors List
Bear Stearns
Bear Stearns investment in Series D - Agensys
Tekla Capital Management
Tekla Capital Management investment in Series D - Agensys
OrbiMed
OrbiMed investment in Series D - Agensys
Innovis Investments
Innovis Investments investment in Series D - Agensys
Lombard Odier
Lombard Odier investment in Series D - Agensys
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series D - Agensys
Alta Partners
Alta Partners investment in Series D - Agensys
JAFCO Asia
JAFCO Asia investment in Series D - Agensys
Nextech Invest
Nextech Invest investment in Series D - Agensys
Duquesne Capital Management
Duquesne Capital Management investment in Series D - Agensys
